LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 10 of 15: Cell count and normalized growth rate inhibition values within biological replicate 3. - Dataset (ID:20247)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Replicate | Assay Well | Timepoint | Timepoint Unit | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MCF7 | Gefitinib | 0.04 | uM | LJP6 | 3 | N12 | 72 | hr | 1209 | 4050 | 4121 | 0.9827 | 0.9804 |
| MCF7 | Gefitinib | 0.12 | uM | LJP6 | 1 | N11 | 72 | hr | 1209 | 3833 | 3823 | 1.0026 | 1.0031 |
| MCF7 | Gefitinib | 0.12 | uM | LJP6 | 2 | N11 | 72 | hr | 1209 | 3828 | 4093 | 0.9351 | 0.9251 |
| MCF7 | Gefitinib | 0.12 | uM | LJP6 | 3 | N11 | 72 | hr | 1209 | 4288 | 4121 | 1.0405 | 1.0454 |
| MCF7 | Gefitinib | 0.37 | uM | LJP6 | 1 | N10 | 72 | hr | 1209 | 3637 | 3823 | 0.9514 | 0.9408 |
| MCF7 | Gefitinib | 0.37 | uM | LJP6 | 2 | N10 | 72 | hr | 1209 | 4217 | 4093 | 1.0301 | 1.0340 |
| MCF7 | Gefitinib | 0.37 | uM | LJP6 | 3 | N10 | 72 | hr | 1209 | 3842 | 4121 | 0.9323 | 0.9222 |
| MCF7 | Gefitinib | 1.11 | uM | LJP6 | 1 | N09 | 72 | hr | 1209 | 3688 | 3823 | 0.9647 | 0.9572 |
| MCF7 | Gefitinib | 1.11 | uM | LJP6 | 2 | N09 | 72 | hr | 1209 | 4245 | 4093 | 1.0369 | 1.0416 |
| MCF7 | Gefitinib | 1.11 | uM | LJP6 | 3 | N09 | 72 | hr | 1209 | 4229 | 4121 | 1.0262 | 1.0294 |
| MCF7 | Gefitinib | 3.33 | uM | LJP6 | 1 | N08 | 72 | hr | 1209 | 3584 | 3823 | 0.9375 | 0.9237 |
| MCF7 | Gefitinib | 3.33 | uM | LJP6 | 2 | N08 | 72 | hr | 1209 | 4089 | 4093 | 0.9988 | 0.9987 |
| MCF7 | Gefitinib | 3.33 | uM | LJP6 | 3 | N08 | 72 | hr | 1209 | 4095 | 4121 | 0.9936 | 0.9928 |
| MCF7 | Gefitinib | 10 | uM | LJP6 | 1 | N07 | 72 | hr | 1209 | 3125 | 3823 | 0.8174 | 0.7713 |
| MCF7 | Gefitinib | 10 | uM | LJP6 | 2 | N07 | 72 | hr | 1209 | 3266 | 4093 | 0.7978 | 0.7589 |
| MCF7 | Gefitinib | 10 | uM | LJP6 | 3 | N07 | 72 | hr | 1209 | 3305 | 4121 | 0.8020 | 0.7654 |
| MCF7 | Nilotinib | 0.04 | uM | LJP5 | 1 | N18 | 72 | hr | 1209 | 4114 | 3980 | 1.0336 | 1.0389 |
| MCF7 | Nilotinib | 0.04 | uM | LJP5 | 2 | N18 | 72 | hr | 1209 | 4353 | 4252 | 1.0236 | 1.0258 |
| MCF7 | Nilotinib | 0.04 | uM | LJP5 | 3 | N18 | 72 | hr | 1209 | 4206 | 4376 | 0.9611 | 0.9577 |
| MCF7 | Nilotinib | 0.12 | uM | LJP5 | 1 | N17 | 72 | hr | 1209 | 3614 | 3980 | 0.9080 | 0.8908 |
| MCF7 | Nilotinib | 0.12 | uM | LJP5 | 2 | N17 | 72 | hr | 1209 | 4475 | 4252 | 1.0523 | 1.0570 |
| MCF7 | Nilotinib | 0.12 | uM | LJP5 | 3 | N17 | 72 | hr | 1209 | 4528 | 4376 | 1.0347 | 1.0371 |
| MCF7 | Nilotinib | 0.37 | uM | LJP5 | 1 | N16 | 72 | hr | 1209 | 4006 | 3980 | 1.0065 | 1.0076 |
| MCF7 | Nilotinib | 0.37 | uM | LJP5 | 2 | N16 | 72 | hr | 1209 | 4154 | 4252 | 0.9768 | 0.9743 |
| MCF7 | Nilotinib | 0.37 | uM | LJP5 | 3 | N16 | 72 | hr | 1209 | 3881 | 4376 | 0.8869 | 0.8747 |